K. Noonan

发表

I. Borrello, Ivan Borrello, K. Noonan, 2011, Cancer Microenvironment.

Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

G. Rosner, C. Huff, D. Pardoll, 2015, Science Translational Medicine.

High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor Cells

V. Bronte, I. Borrello, P. Serafini, 2004, Cancer Research.

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

J. Califano, V. Bronte, I. Borrello, 2006, The Journal of experimental medicine.

THE IMPACT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING ON THE DAILY FUNCTION AND QUALITY OF LIFE OF PATIENTS

K. Noonan, 2005 .

regulatory T cells following stem-cell transplantation Escape from suppression: tumor-specific effector cells outcompete

P. Mirmonsef, I. Borrello, K. Noonan, 2013 .

Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation.

P. Mirmonsef, H. Levitsky, I. Borrello, 2006, Blood.

Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma

M. Bui, N. Ghosh, I. Borrello, 2014, Cancer Immunology Research.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Eun Jeong Kim, P. Bierman, D. Ettinger, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Eun Jeong Kim, P. Bierman, D. Ettinger, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

AntiemesisPractice Guidelines in Oncology TM

P. Bierman, D. Ettinger, M. Kris, 2009 .

Antiemesis clinical practice guidelines in oncology.

P. Bierman, D. Ettinger, M. Kris, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

The Immunomodulatory Role of Lenalidomide on Prevnar® Responses in Patients with Relapsed Multiple Myeloma: A Comprehensive Analysis of the Immune Response

C. Huff, I. Borrello, R. Knight, 2008 .

NCCN antiemesis practice guidelines.

D. Ettinger, M. Kris, M. Levy, 1997, Oncology.

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.

I. Borrello, P. Serafini, K. Noonan, 2008, Cancer research.

Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

S. Goodman, R. Blanco, G. Neuner, 2015, Clinical Cancer Research.

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

A. Zhavoronkov, L. Marchionni, D. Sidransky, 2018, Nature Communications.

9209 Safety of romiplostim for treatment of severe chemotherapy induced thrombocytopenia (CIT) in patients with lymphoma receiving multi-cycle chemotherapy: results from an open-label dose- and schedule-finding study

P. Stiff, M. Fanale, C. Moskowitz, 2009 .

Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy

C. Chung, E. Fertig, J. Califano, 2012, Molecular Cancer Therapeutics.

An Allogeneic Multiple Myeloma GM-CSF–Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission

M. Vignali, C. Huff, C. Sanders, 2021, Clinical Cancer Research.

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

M. Goswami, C. Hourigan, B. Smith, 2017, Journal of Translational Medicine.

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

A. Zhavoronkov, L. Marchionni, D. Sidransky, 2018, Nature Communications.

A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.

L. Marchionni, D. Pardoll, I. Borrello, 2010, Blood.

Marrow-Infiltrating Lymphocytes (MILs) Provide a Robust Platform for CAR-T Cell Therapy

I. Weiss, Eric R. Lutz, I. Borrello, 2018, Blood.

Persistence of Non Gene-Modified Adoptively Transferred Marrow Infiltrating Lymphocytes (MILs) More Than Five Years Post Transfer

Eric R. Lutz, I. Borrello, V. Hoyos, 2016 .

Marrow-Infiltrating Lymphocytes – Role in Biology and Cancer Therapy

I. Borrello, K. Noonan, 2016, Front. Immunol..

Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors.

W. Matsui, H. Levitsky, I. Borrello, 2005, Cancer research.

Activated Allogeneic Donor-derived Marrow-infiltrating Lymphocytes Display Measurable In Vitro Antitumor Activity

I. Borrello, L. Luznik, K. Noonan, 2019, Journal of immunotherapy.

Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses

C. Huff, I. Borrello, K. Noonan, 2012, Clinical Cancer Research.

Flow cytometric discrimination of seven lineage markers by using two fluorochromes

I. Borrello, M. Soloski, K. Noonan, 2017, PloS one.

Th-17 Lymphocytes, Not Regulatory T Cells, Mediate Immune Regulation of Bone Marrow Infiltrating Lymphocytes and Induce Osteoclast Activation in Multiple Myeloma.

I. Borrello, P. Serafini, K. Noonan, 2007 .

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

M. Goswami, C. Hourigan, B. Smith, 2017, Journal of Translational Medicine.

Marrow Infiltrating Lymphocytes: Their Role in Adoptive Immunotherapy

I. Borrello, K. Noonan, 2015, Cancer journal.

Priority Brief Report Targeting Immune Suppression with PDE-5 Inhibition in End-Stage Multiple Myeloma

N. Ghosh, I. Borrello, K. Noonan, 2014 .

Administration Of An Oral PDE5 Inhibitor, Tadalafil In Conjunction With a Lenalidomide Containing Regimen In Patients With Multiple Myeloma

C. Huff, X. Ye, N. Ghosh, 2013 .

Phase I/II Study of Marrow Infiltrating Lymphocytes (MILs) Generates Measurable Myeloma-Specific Immunity in the Autologous Stem Cell Transplant (SCT) Setting

C. Huff, Richard J. Jones, J. Powell, 2011 .

CD4+CD25+ Marrow Infiltrating Lymphocytes in Myeloma Patients Display an Activated Phenotype and Lack Suppressive Function.

I. Borrello, P. Serafini, K. Noonan, 2006 .

Lenalidomide Augments Immune Responses to Prevnar Vaccination in Relapsed Myeloma Patients: Implications for Cancer and Infectious Vaccines.

C. Huff, P. Schafer, I. Borrello, 2009 .

Marrow Infiltrating Lymphocytes: Their Role in Adoptive Immunotherapy

I. Borrello, K. Noonan, 2015, Cancer journal.